— Know what they know.
Not Investment Advice
Also trades as: ZIM.DE (XETRA) · $vol 0M · ZBH.SW (SIX) · $vol 0M

ZBH NYSE

Zimmer Biomet Holdings, Inc.
1W: +3.2% 1M: -8.3% 3M: -13.6% YTD: -5.2% 1Y: -10.1% 3Y: -35.6% 5Y: -45.7%
$85.50
+0.19 (+0.22%)
 
Weekly Expected Move ±6.8%
$72 $78 $84 $89 $95
NYSE · Healthcare · Medical - Devices · Alpha Radar Sell · Power 43 · $16.5B mcap · 193M float · 1.18% daily turnover · Short 62% of daily vol

Cash Flow Trends

Operating Cash Flow
$1.7B +13.2% ▲
5Y CAGR: +7.1%
Capital Expenditures
$224M +37.1% ▲
5Y CAGR: +14.9%
Free Cash Flow
$1.5B +28.9% ▲
5Y CAGR: +6.1%
Dividends Paid
$190M +2.9% ▲
Buybacks
$487M +43.9% ▲
Net Change in Cash
$66M -39.5% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$446M$291M$1.0B$905M$705M
Depreciation & Amort.$938M$926M$952M$996M$1.1B
Stock-Based Comp.$76M$105M$100M$101M$0
Change in Working Capital-$134M-$311M-$396M-$455M-$105M
Other Non-Cash Items$276M$338M-$2M$0$90M
Operating Cash Flow$1.5B$1.3B$1.6B$1.5B$1.7B
— Investing Activities —
Capital Expenditures-$144M-$188M-$291M-$204M-$277M
Acquisitions (Net)$0-$100M-$135M-$276M-$1.4B
Investment Purchases-$274M-$258M-$312M-$240M-$301M
Investment Sales$2M$89M$33M$22M$0
Other Investing-$88M-$73M-$75M-$190M-$5M
Investing Cash Flow-$504M-$529M-$779M-$888M-$2.0B
— Financing Activities —
Net Debt Issuance-$1.1B-$1.1B$55M$536M$1.0B
Stock Repurchased$0-$126M-$692M-$868M-$487M
Dividends Paid-$200M-$201M-$201M-$196M-$190M
Other Financing-$51M$544M$75M$43M-$43M
Financing Cash Flow-$1.3B-$844M-$764M-$484M$326M
Net Change in Cash-$324M-$103M$40M$110M$66M
Cash End of Period$478M$376M$416M$526M$592M
Free Cash Flow$1.3B$1.1B$1.2B$1.1B$1.5B

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms